Fulden Sarac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fulden Sarac has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Sumru Savas
Section of Geriatrics, Department of Internal Medicine, School of Medicine, Ege University, Izmir, Turkey
5 shared publications Fehmi Akcicek
4 shared publicationsPelin Tutuncuoglu
4 shared publicationsMehmet Tüzün
3 shared publicationsA. Gökhan Özgen
Ege University Medical School
2 shared publicationsKemal Öztekin
Ege University Faculty, Department of Gynecology and Obstetrics, Ege University School of Medicine, Bornova, Izmir, Izmir 35100, Turkey
2 shared publications
Latest Publications
- 8 May 2018
- Published by Bioscientifica in Endocrine Abstracts
Evaluation of tumor size and hormonal status of elderly with adrenal incidentaloma
Incidentalomas (AI) are clinically inapparent adrenal masses. Patients present hormone excess or mass effect, but part of them is clinically silent. They are discovered inadvertently in the course of diagnostic testing or treatment for other clinical conditions. The aim of the study was to investigate the clinical value of tumor size and hormonal status of elderly patients with adrenal incidentaloma (AI). Subjects and Methods: Forty-four elderly with AI was diagnosed AI discovered by magnetic resonance (MR). The demographics of patients, imaging features, functional status and histological results were evaluated, retrospectively. Results: Thirty-two (72.7%) of the patients were females and 12 (27.7%) of them were males. Mean age of the patients was 69.1±13.0 years. 5 (11.3%) of the patients’ age were ≥75 years. Mean volumes of AI found to be 3.12±0.7 cm. In 6 (50.0%) of the elderly male with AI, sizes of tumor found to be ≥3.5 cm and were operated. Histological findings in operated male were myelolipoma (two male patients) and metastatic epidermoid cancer originating from lung (two male patients). Mean levels of Dehydroepiandrosterone (DHEAS), cortisol, vanil mandelic acid (VMA), aldosteron, 17-hydroxyprogesterone (17-OHP) were found to be 289.3±89.2 (ng/ml); 15.3±3.56 (μg/dl); 4.0±1.1 (mg/24 h); 121.1±21.3 (pg/mL); 1.0±0.3 (ng/ml) respectively. Conclusion: The frequency of AI in the female elderly was higher than thats of male elderly. However, mean levels of tumor size in male elderly than thats of female elderly. This is a preliminary report, future studies are needed.
- 8 May 2018
- Published by Bioscientifica in Endocrine Abstracts
Evaluation of tumor size and hormonal status of elderly with adrenal incidentaloma
Incidentalomas (AI) are clinically inapparent adrenal masses. Patients present hormone excess or mass effect, but part of them is clinically silent. They are discovered inadvertently in the course of diagnostic testing or treatment for other clinical conditions. The aim of the study was to investigate the clinical value of tumor size and hormonal status of elderly patients with adrenal incidentaloma (AI). Subjects and Methods: Forty-four elderly with AI was diagnosed AI discovered by magnetic resonance (MR). The demographics of patients, imaging features, functional status and histological results were evaluated, retrospectively. Results: Thirty-two (72.7%) of the patients were females and 12 (27.7%) of them were males. Mean age of the patients was 69.1±13.0 years. 5 (11.3%) of the patients’ age were ≥75 years. Mean volumes of AI found to be 3.12±0.7 cm. In 6 (50.0%) of the elderly male with AI, sizes of tumor found to be ≥3.5 cm and were operated. Histological findings in operated male were myelolipoma (two male patients) and metastatic epidermoid cancer originating from lung (two male patients). Mean levels of Dehydroepiandrosterone (DHEAS), cortisol, vanil mandelic acid (VMA), aldosteron, 17-hydroxyprogesterone (17-OHP) were found to be 289.3±89.2 (ng/ml); 15.3±3.56 (μg/dl); 4.0±1.1 (mg/24 h); 121.1±21.3 (pg/mL); 1.0±0.3 (ng/ml) respectively. Conclusion: The frequency of AI in the female elderly was higher than thats of male elderly. However, mean levels of tumor size in male elderly than thats of female elderly. This is a preliminary report, future studies are needed.
- 8 May 2018
- Published by Bioscientifica in Endocrine Abstracts
Evaluation of causes of high parathyroid hormone levels in elderly
Primary hyperparathyroidism (PHPT) predominantly affects the elderly, with a peak incidence between ages 55 and 70. Parathyroid adenoma is the principal cause, representing 80–85% of all cases. The aim of the study to determine the frequency of parathyroid adenoma in elderly with high parathyroid hormone levels. Subjects and methods: We performed a retrospective analysis of 31 (30 female, 1 male) elderly wih high parathyroid hormone levels. The demographic caracteristics, biochemical tests and imaging features such as neck ultrasound and parathyroid scintigraphy were evaluated, retrospectively. Results: The patients had a mean age of 67±8.1 years, serum Ca of 10.9±0.5 mg/dl, serum PTH of 110.6±15.2 pg/ml, serum 25-hydroxy-vitamin D (25- OH D) of 22.9±1.1 nmol/l. Two female patients 2/31) had a parathyroid adenoma shown on a sestamibi scan and neck ultrasound. The frequency of parathyroid adenoma was found to be 6.4%. These patients were underwent parathyroidectomy for primary hyperparathyroidism. 1 patient presented with severe abdominal pain diagnosed as parathyroid adenoma. Surgery was successful in all patients with no postoperative mortality. 12 patients had low serum 25- OH D (17.3±3.9 nmol/l). Frequency of deficiency of vitamin D was 38.7%. And also, they treated with D vitamin and decreased their PTH levels. No cause was found related hyperparathyroidism with normal 25- OH D using imaging in the rest of them. Conclusion: High PTH levels due to deficiency of D vitamin levels were higher than parathyroid adenoma in elderly.
- 8 May 2018
- Published by Bioscientifica in Endocrine Abstracts
Evaluation of causes of high parathyroid hormone levels in elderly
Primary hyperparathyroidism (PHPT) predominantly affects the elderly, with a peak incidence between ages 55 and 70. Parathyroid adenoma is the principal cause, representing 80–85% of all cases. The aim of the study to determine the frequency of parathyroid adenoma in elderly with high parathyroid hormone levels. Subjects and methods: We performed a retrospective analysis of 31 (30 female, 1 male) elderly wih high parathyroid hormone levels. The demographic caracteristics, biochemical tests and imaging features such as neck ultrasound and parathyroid scintigraphy were evaluated, retrospectively. Results: The patients had a mean age of 67±8.1 years, serum Ca of 10.9±0.5 mg/dl, serum PTH of 110.6±15.2 pg/ml, serum 25-hydroxy-vitamin D (25- OH D) of 22.9±1.1 nmol/l. Two female patients 2/31) had a parathyroid adenoma shown on a sestamibi scan and neck ultrasound. The frequency of parathyroid adenoma was found to be 6.4%. These patients were underwent parathyroidectomy for primary hyperparathyroidism. 1 patient presented with severe abdominal pain diagnosed as parathyroid adenoma. Surgery was successful in all patients with no postoperative mortality. 12 patients had low serum 25- OH D (17.3±3.9 nmol/l). Frequency of deficiency of vitamin D was 38.7%. And also, they treated with D vitamin and decreased their PTH levels. No cause was found related hyperparathyroidism with normal 25- OH D using imaging in the rest of them. Conclusion: High PTH levels due to deficiency of D vitamin levels were higher than parathyroid adenoma in elderly.
- 8 May 2018
- Published by Bioscientifica in Endocrine Abstracts
Relationships between vitamins and lipids in the elderly
Objective: In recent years, many studies have been conducted on the beneficial effects of vitamin D. Vitamin D have many important effects on calcium metabolism, skeletal system and also on different systems. Low serum vitamin D levels are predictors of type 2 diabetes mellitus, cancer, cardiovascular diseases, immunological diseases and even mortality. The relationships between vitamin D and cardiovascular diseases can be explained by the lipid-lowering effect of vitamin D. In many studies, there is general agreement that high serum vitamin D levels are associated with a healthy serum lipid profile. The aim of this study was to investigate whether vitamin D levels are associated with lipid levels in outpatients, and to compare the patients above and below 60 years of age. Material and methods: The medical records of patients who applied to outpatient clinic between January 2015 and August 2017 were reviewed. 236 outpatients aged 19–88 years who had serum 25-hydroxyvitamin D (25(OH)D) levels, total cholesterol, LDL-cholesterol, high density lipoprotein (HDL) cholesterol and triglyceride levels were included in the study. Patients’ body mass index (BMI) was calculated. Overweight was defined as BMI (kg/m2) between 25.0 and 29.9 and obesity was defined as BMI ≥30.0. Total cholesterol levels ≥200 mg/dl, LDL cholesterol levels ≥140 mg/dl and triglyceride levels ≥ 150 mg/dl were classified as high. HDL-cholesterol levels <40 mg/dl were defined as low. Serum 25(OH)D level <50 nmol/l, or <20 ng/ml, is an indication of vitamin D deficiency. Results: This study was conducted with 236 outpatients aged 19–88 years. 46.2% of the study population were over 60 years old, 83.5% were female, 18.2% were normal weight, 50.4% were overweight and 31.4% were obese. 56.8% of the outpatients had high total cholesterol levels, 38.1% of had high LDL cholesterol levels and 30.1% of had high triglyceride levels. 14% of the outpatients had low HDL cholesterol levels. The prevalance of vitamin D deficiency was 49.6% (95% CI, 41–58%). Conclusion: Patients with increased 25(OH)D levels in epidemiological studies; there was a significant decrease in total cholesterol, LDL cholesterol and triglyceride levels and an increase in HDL cholesterol levels (1–3). But, in our study, there was no statistically significant relationship between vitamin D deficiency and lipid profile in patients over 60 years and under 60 years of age. We planned to increase the number of patients.
- 8 May 2018
- Published by Bioscientifica in Endocrine Abstracts
Relationships between vitamins and lipids in the elderly
Objective: In recent years, many studies have been conducted on the beneficial effects of vitamin D. Vitamin D have many important effects on calcium metabolism, skeletal system and also on different systems. Low serum vitamin D levels are predictors of type 2 diabetes mellitus, cancer, cardiovascular diseases, immunological diseases and even mortality. The relationships between vitamin D and cardiovascular diseases can be explained by the lipid-lowering effect of vitamin D. In many studies, there is general agreement that high serum vitamin D levels are associated with a healthy serum lipid profile. The aim of this study was to investigate whether vitamin D levels are associated with lipid levels in outpatients, and to compare the patients above and below 60 years of age. Material and methods: The medical records of patients who applied to outpatient clinic between January 2015 and August 2017 were reviewed. 236 outpatients aged 19–88 years who had serum 25-hydroxyvitamin D (25(OH)D) levels, total cholesterol, LDL-cholesterol, high density lipoprotein (HDL) cholesterol and triglyceride levels were included in the study. Patients’ body mass index (BMI) was calculated. Overweight was defined as BMI (kg/m2) between 25.0 and 29.9 and obesity was defined as BMI ≥30.0. Total cholesterol levels ≥200 mg/dl, LDL cholesterol levels ≥140 mg/dl and triglyceride levels ≥ 150 mg/dl were classified as high. HDL-cholesterol levels <40 mg/dl were defined as low. Serum 25(OH)D level <50 nmol/l, or <20 ng/ml, is an indication of vitamin D deficiency. Results: This study was conducted with 236 outpatients aged 19–88 years. 46.2% of the study population were over 60 years old, 83.5% were female, 18.2% were normal weight, 50.4% were overweight and 31.4% were obese. 56.8% of the outpatients had high total cholesterol levels, 38.1% of had high LDL cholesterol levels and 30.1% of had high triglyceride levels. 14% of the outpatients had low HDL cholesterol levels. The prevalance of vitamin D deficiency was 49.6% (95% CI, 41–58%). Conclusion: Patients with increased 25(OH)D levels in epidemiological studies; there was a significant decrease in total cholesterol, LDL cholesterol and triglyceride levels and an increase in HDL cholesterol levels (1–3). But, in our study, there was no statistically significant relationship between vitamin D deficiency and lipid profile in patients over 60 years and under 60 years of age. We planned to increase the number of patients.
- 1 May 2015
- Published by Bioscientifica in Endocrine Abstracts
25-Hydroxyvitamin D status in elderly patients with Hashimoto[apos]s thyroiditis
Introduction: Low serum levels of 25-hydroxyvitamin D (25(OH)D3) lower than has been reported to be prevalent in several autoimmune diseases. The aims of the study were i) to evaluate the 25(OH)D3 levels in patients with Hashimato’s thyroiditis (HT) and ii) to investigate the relationships between 25(OH)D3, TSH, free T4, free T3, and anti-thyroid peroxidase (anti-TPO) levels in elderly patients with HT. Subjects and method: Study population included 80 (mean age 58.1±9.3 years; 60 females and 20 males) patients with HT. Data such as 25(OH)D3, TSH, fT4, fT3, and anti-TPO tests were retrospectively searched. Vitamin D insufficiency was defined as 25(OH)D3 concentrations lower than 30 ng/ml. Results: In elderly with HT, mean levels of 25(OH)D3 were found to be 39.7±6.5 ng/ml. However, mean levels of 25(OH)D3 were 52.0±12.3 ng/ml in patients with HT (age P=0.05). In patients with HT (age r=−0.700, P=0.04). And also, in elderly group, mean levels of 25(OH)D3 concentrations were positively correlated with the fT4 levels (r=−0.700, P=0.04). Conclusion: 25(OH)D3 deficiency was significantly higher in elderly. And also, mean levels of 25(OH)D3 were positively correlated with fT4 in elderly with HT, but inversely correlated with anti-TPO levels in patients with HT (age <60 years).
- 1 May 2015
- Published by Bioscientifica in Endocrine Abstracts
25-Hydroxyvitamin D status in elderly patients with Hashimoto[apos]s thyroiditis
Introduction: Low serum levels of 25-hydroxyvitamin D (25(OH)D3) lower than has been reported to be prevalent in several autoimmune diseases. The aims of the study were i) to evaluate the 25(OH)D3 levels in patients with Hashimato’s thyroiditis (HT) and ii) to investigate the relationships between 25(OH)D3, TSH, free T4, free T3, and anti-thyroid peroxidase (anti-TPO) levels in elderly patients with HT. Subjects and method: Study population included 80 (mean age 58.1±9.3 years; 60 females and 20 males) patients with HT. Data such as 25(OH)D3, TSH, fT4, fT3, and anti-TPO tests were retrospectively searched. Vitamin D insufficiency was defined as 25(OH)D3 concentrations lower than 30 ng/ml. Results: In elderly with HT, mean levels of 25(OH)D3 were found to be 39.7±6.5 ng/ml. However, mean levels of 25(OH)D3 were 52.0±12.3 ng/ml in patients with HT (age P=0.05). In patients with HT (age r=−0.700, P=0.04). And also, in elderly group, mean levels of 25(OH)D3 concentrations were positively correlated with the fT4 levels (r=−0.700, P=0.04). Conclusion: 25(OH)D3 deficiency was significantly higher in elderly. And also, mean levels of 25(OH)D3 were positively correlated with fT4 in elderly with HT, but inversely correlated with anti-TPO levels in patients with HT (age <60 years).
- Open Access
- 11 March 2014
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2014, 1-5
Detection of Impaired Cognitive Function in Rat with Hepatosteatosis Model and Improving Effect of GLP-1 Analogs (Exenatide) on Cognitive Function in Hepatosteatosis
The aims of the study were to evaluate (1) detection of cognitive function changing in rat with hepatosteatosis model and (2) evaluate the effect of GLP-1 analog (exenatide) on cognitive function in hepatosteatosis. In the study group, 30% fructose was given in nutrition water to perform hepatosteatosis for 8 weeks to 18 male rats. Six male rats were chosen as control group and had normal nutrition. Fructose nutrition group were stratified into 3 groups. In first group (), intracerebroventricular (ICV) infusion of exenatide () was given. ICV infusion of NaCl () was given to second group. And also, the third group had no treatment. And also, rats were evaluated for passive avoidance learning (PAL) and liver histopathology. Mean levels of latency time were statistically significantly decreased in rats with hepatosteatosis than those of normal rats (). However, mean level of latency time in rats with hepatosteatosis treated with ICV exenatide was statistically significantly increased than that of rats treated with ICV NaCl (). Memory performance falls off in rats with hepatosteatosis feeding on fructose (decreased latency time). However, GLP-1 ameliorates cognitive functions (increased latency time) in rats with hepatosteatosis and releated metabolic syndrome.- 11 March 2014
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2014, 1-5
Open AccessDetection of Impaired Cognitive Function in Rat with Hepatosteatosis Model and Improving Effect of GLP-1 Analogs (Exenatide) on Cognitive Function in Hepatosteatosis
The aims of the study were to evaluate (1) detection of cognitive function changing in rat with hepatosteatosis model and (2) evaluate the effect of GLP-1 analog (exenatide) on cognitive function in hepatosteatosis. In the study group, 30% fructose was given in nutrition water to perform hepatosteatosis for 8 weeks to 18 male rats. Six male rats were chosen as control group and had normal nutrition. Fructose nutrition group were stratified into 3 groups. In first group (), intracerebroventricular (ICV) infusion of exenatide () was given. ICV infusion of NaCl () was given to second group. And also, the third group had no treatment. And also, rats were evaluated for passive avoidance learning (PAL) and liver histopathology. Mean levels of latency time were statistically significantly decreased in rats with hepatosteatosis than those of normal rats (). However, mean level of latency time in rats with hepatosteatosis treated with ICV exenatide was statistically significantly increased than that of rats treated with ICV NaCl (). Memory performance falls off in rats with hepatosteatosis feeding on fructose (decreased latency time). However, GLP-1 ameliorates cognitive functions (increased latency time) in rats with hepatosteatosis and releated metabolic syndrome. - 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
The characteristics of thyroid pathology in patients with parathyroid adenoma
Introduction: Thyroid and parathyroid pathology may coexist; classically, this is described in multiple endocrine neoplasia. Other nonsyndromic scenarios result in pathologies of these endocrine organs coexisting. The aim of the investigation the chracteristics of thyroid pathology in patients with parathyroid adenoma. Subjects and method: The study population included 42 (26 patients age 3, free T4, autoantibody against thyroid peroxidase (TPOAb) and autoantibody against thyroglobulin (TgAb) were found to be 169.9±23.7 pg/ml, 11.4±1.1 mg/dl, 4.1±0.9 μIU/ml, 2.4±0.8 pg/ml, 0.91±0.01 ng/dl, 123.7±31.7 IU/ml and 57.0±10.3 IU/ml, respectively. Of the 16 patients, 15 (93.7%) had thyroid nodules. Among 15 patients with thyroid nodules, 1 (6.6%) had malignant thyroid tumor. And also, 7 patients (43.7%) had hashimato thyroiditis. In patients with age 3, free T4, autoantibody against thyroid peroxidase (TPOAb) and autoantibody against thyroglobulin (TgAb) were measured 121.9±34.0 pg/ml, 12.3±2.0 mg/dl, 2.9±0.8 μIU/ml, 2.7±0.9 pg/ml, 1.1±0.1 ng/dl, 190.1±42.9 IU/ml and 76.8±12.1 IU/ml, respectively. Of the 26 patients, 19 (73.0%) had thyroid nodules. Among 19 patients with thyroid nodules, 2 (10.5%) had malignant thyroid tumor. And also, 12 patients (46.1%) had hashimato thyroiditis. Conclusions: The study was demonstrated that the frequency of thyroide pathologies were high in patients with parathyroid adenoma. And also, the frequency of thyroid nodules were higher in patients with age ≥60 years than thats of patients with age <60 years.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
The characteristics of thyroid pathology in patients with parathyroid adenoma
Introduction: Thyroid and parathyroid pathology may coexist; classically, this is described in multiple endocrine neoplasia. Other nonsyndromic scenarios result in pathologies of these endocrine organs coexisting. The aim of the investigation the chracteristics of thyroid pathology in patients with parathyroid adenoma. Subjects and method: The study population included 42 (26 patients age 3, free T4, autoantibody against thyroid peroxidase (TPOAb) and autoantibody against thyroglobulin (TgAb) were found to be 169.9±23.7 pg/ml, 11.4±1.1 mg/dl, 4.1±0.9 μIU/ml, 2.4±0.8 pg/ml, 0.91±0.01 ng/dl, 123.7±31.7 IU/ml and 57.0±10.3 IU/ml, respectively. Of the 16 patients, 15 (93.7%) had thyroid nodules. Among 15 patients with thyroid nodules, 1 (6.6%) had malignant thyroid tumor. And also, 7 patients (43.7%) had hashimato thyroiditis. In patients with age 3, free T4, autoantibody against thyroid peroxidase (TPOAb) and autoantibody against thyroglobulin (TgAb) were measured 121.9±34.0 pg/ml, 12.3±2.0 mg/dl, 2.9±0.8 μIU/ml, 2.7±0.9 pg/ml, 1.1±0.1 ng/dl, 190.1±42.9 IU/ml and 76.8±12.1 IU/ml, respectively. Of the 26 patients, 19 (73.0%) had thyroid nodules. Among 19 patients with thyroid nodules, 2 (10.5%) had malignant thyroid tumor. And also, 12 patients (46.1%) had hashimato thyroiditis. Conclusions: The study was demonstrated that the frequency of thyroide pathologies were high in patients with parathyroid adenoma. And also, the frequency of thyroid nodules were higher in patients with age ≥60 years than thats of patients with age <60 years.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
Endocrine functions in premenopausal and postmenopausal women
Introduction: The anabolic hormones, namely GH, testosterone and dehydroepiandrosterone, as well as the reproductive function of women, enter a period of progressive insufficiency which is characteristically designated as somatopause, andropause and adrenopause respectively. The aim of the study was to compare the endocrine functions between premenopausal and postmenopausal women. Subjects and methods: The study was included 40 premenopausal (mean age 34.9±4.8 years) and 40 post menopasal women (mean age 65.1±8.6 years) GH, free thyroxine (FT4), free triidotironin, TSH, adrenocorticortropichormone (ACTH), cortisol (COR), dehydoepiandrosteronesulfat (DHEA-S), FSH, LH, prolactin (PRL), testosterone, estradiol (E2) and fasting insulin levels were measured in all patients. Results: Mean levels of FSH (P=0.04), LH (P=0.02), COR (P=0.01), ACTH (PP=0.02) in post menopausal were higher than that of premenopausal women. However, E2 (P=0.04), TSH (P=0.01), FT4 (P=0.001), PRL (P=0.05) and DHEA-S (P=0.01) levels were lower in post menopausal than premenopausal women. Conclusion: The study demonstrated that E2, TSH, FT4, PRL and DHEA-S levels were decreased with aging.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
Endocrine functions in premenopausal and postmenopausal women
Introduction: The anabolic hormones, namely GH, testosterone and dehydroepiandrosterone, as well as the reproductive function of women, enter a period of progressive insufficiency which is characteristically designated as somatopause, andropause and adrenopause respectively. The aim of the study was to compare the endocrine functions between premenopausal and postmenopausal women. Subjects and methods: The study was included 40 premenopausal (mean age 34.9±4.8 years) and 40 post menopasal women (mean age 65.1±8.6 years) GH, free thyroxine (FT4), free triidotironin, TSH, adrenocorticortropichormone (ACTH), cortisol (COR), dehydoepiandrosteronesulfat (DHEA-S), FSH, LH, prolactin (PRL), testosterone, estradiol (E2) and fasting insulin levels were measured in all patients. Results: Mean levels of FSH (P=0.04), LH (P=0.02), COR (P=0.01), ACTH (PP=0.02) in post menopausal were higher than that of premenopausal women. However, E2 (P=0.04), TSH (P=0.01), FT4 (P=0.001), PRL (P=0.05) and DHEA-S (P=0.01) levels were lower in post menopausal than premenopausal women. Conclusion: The study demonstrated that E2, TSH, FT4, PRL and DHEA-S levels were decreased with aging.
- 1 January 2012
- Published by ACTA Endocrinologica Foundation in Acta Endocrinologica (Bucharest)
- Vol. 8 (4) , 565-574
Polymorphisms in heterozygous and homozygous perilipin gene, C.113T>C and C.1119C>T, are increased in obese women
- 1 January 2012
- Published by ACTA Endocrinologica Foundation in Acta Endocrinologica (Bucharest)
- Vol. 8 (4) , 565-574
Polymorphisms in heterozygous and homozygous perilipin gene, C.113T>C and C.1119C>T, are increased in obese women
- 8 June 2010
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 27 (4) , 273-278
Early menopause association with employment, smoking, divorced marital status and low leptin levels
Aims. The aims of this study were (1) to investigate the determining risk factors related to early menopause and (2) to compare the relationships between demographic characteristics and hormonal status and leptin levels in subjects with early (no surgical) and natural menopause. Study design. The prospective study was conducted on 500 women with early and 2700 women with natural menopause. Detailed information was collected about their employment status, past and present smoking habits, coffee and alcohol use, educational level and other factors relevant to health. Thirty participants with early menopause and 30 participants with natural menopause were evaluated for hormone and leptin levels. Results. Employment status (OR: 1.94), current smoking (OR: 1.80) and divorced marital status (OR: 1.79) were found to be significant risk factors for early menopause. Mean levels of leptin in natural and early menopause were measured 11.40 ± 4.1 ng/ml and 8.01 ± 3.9 ng/ml, respectively (p = 0001). Leptin levels in the early (r = 0.765, p = 0.001) and natural (r = 0.750, p = 0.001) menopause subjects correlated positively with oestradiol (E2) levels. Conclusion. This study shows that early onset of menopause is correlated with smoking, employment status, divorced marital status and lower leptin levels.
- 8 June 2010
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 27 (4) , 273-278
Early menopause association with employment, smoking, divorced marital status and low leptin levels
Aims. The aims of this study were (1) to investigate the determining risk factors related to early menopause and (2) to compare the relationships between demographic characteristics and hormonal status and leptin levels in subjects with early (no surgical) and natural menopause. Study design. The prospective study was conducted on 500 women with early and 2700 women with natural menopause. Detailed information was collected about their employment status, past and present smoking habits, coffee and alcohol use, educational level and other factors relevant to health. Thirty participants with early menopause and 30 participants with natural menopause were evaluated for hormone and leptin levels. Results. Employment status (OR: 1.94), current smoking (OR: 1.80) and divorced marital status (OR: 1.79) were found to be significant risk factors for early menopause. Mean levels of leptin in natural and early menopause were measured 11.40 ± 4.1 ng/ml and 8.01 ± 3.9 ng/ml, respectively (p = 0001). Leptin levels in the early (r = 0.765, p = 0.001) and natural (r = 0.750, p = 0.001) menopause subjects correlated positively with oestradiol (E2) levels. Conclusion. This study shows that early onset of menopause is correlated with smoking, employment status, divorced marital status and lower leptin levels.
- 31 October 2009
- Published by Elsevier in International Journal of Cardiology
- Vol. 137, S104
Benefit effect of valsartan on adhesion molecules in the hypertensive type 2 diabetes mellitus
- 31 October 2009
- Published by Elsevier in International Journal of Cardiology
- Vol. 137, S104
Benefit effect of valsartan on adhesion molecules in the hypertensive type 2 diabetes mellitus